nodes	percent_of_prediction	percent_of_DWPC	metapath
Prednisone—ALB—Fluorouracil—head and neck cancer	0.197	0.414	CbGbCtD
Prednisone—ABCB1—Vinblastine—head and neck cancer	0.0955	0.201	CbGbCtD
Prednisone—ABCB1—Docetaxel—head and neck cancer	0.0787	0.166	CbGbCtD
Prednisone—CYP3A4—Vinblastine—head and neck cancer	0.0572	0.12	CbGbCtD
Prednisone—CYP3A4—Docetaxel—head and neck cancer	0.0472	0.0992	CbGbCtD
Prednisone—Erythema facial—Hydroxyurea—head and neck cancer	0.0266	0.0551	CcSEcCtD
Prednisone—Skin atrophy—Hydroxyurea—head and neck cancer	0.0161	0.0333	CcSEcCtD
Prednisone—Atrophy—Hydroxyurea—head and neck cancer	0.0149	0.0309	CcSEcCtD
Prednisone—Telangiectasia—Fluorouracil—head and neck cancer	0.0148	0.0307	CcSEcCtD
Prednisone—Gastric irritation—Hydroxyurea—head and neck cancer	0.0125	0.0259	CcSEcCtD
Prednisone—Memory loss—Fluorouracil—head and neck cancer	0.0119	0.0246	CcSEcCtD
Prednisone—Epigastric discomfort—Hydroxyurea—head and neck cancer	0.00923	0.0191	CcSEcCtD
Prednisone—Febrile neutropenia—Hydroxyurea—head and neck cancer	0.00807	0.0167	CcSEcCtD
Prednisone—Peptic ulcer—Vinblastine—head and neck cancer	0.00796	0.0165	CcSEcCtD
Prednisone—Neuritis—Vinblastine—head and neck cancer	0.00713	0.0148	CcSEcCtD
Prednisone—Oesophageal ulcer—Docetaxel—head and neck cancer	0.00691	0.0143	CcSEcCtD
Prednisone—Febrile neutropenia—Fluorouracil—head and neck cancer	0.00581	0.012	CcSEcCtD
Prednisone—Amenorrhoea—Hydroxyurea—head and neck cancer	0.00552	0.0114	CcSEcCtD
Prednisone—Ulcer—Hydroxyurea—head and neck cancer	0.00513	0.0106	CcSEcCtD
Prednisone—Lymphopenia—Docetaxel—head and neck cancer	0.00493	0.0102	CcSEcCtD
Prednisone—Skin exfoliation—Hydroxyurea—head and neck cancer	0.00463	0.0096	CcSEcCtD
Prednisone—Menstruation irregular—Docetaxel—head and neck cancer	0.00455	0.00944	CcSEcCtD
Prednisone—Necrosis—Fluorouracil—head and neck cancer	0.00445	0.00922	CcSEcCtD
Prednisone—Pulmonary oedema—Hydroxyurea—head and neck cancer	0.00432	0.00895	CcSEcCtD
Prednisone—Febrile neutropenia—Docetaxel—head and neck cancer	0.00419	0.00869	CcSEcCtD
Prednisone—Embolism—Docetaxel—head and neck cancer	0.00393	0.00814	CcSEcCtD
Prednisone—Leukocytosis—Fluorouracil—head and neck cancer	0.00372	0.0077	CcSEcCtD
Prednisone—Ulcer—Fluorouracil—head and neck cancer	0.00369	0.00765	CcSEcCtD
Prednisone—Dermatitis atopic—Docetaxel—head and neck cancer	0.00341	0.00706	CcSEcCtD
Prednisone—Face oedema—Hydroxyurea—head and neck cancer	0.0034	0.00705	CcSEcCtD
Prednisone—Neuritis—Docetaxel—head and neck cancer	0.00338	0.007	CcSEcCtD
Prednisone—Necrosis—Docetaxel—head and neck cancer	0.00321	0.00666	CcSEcCtD
Prednisone—Oesophagitis—Fluorouracil—head and neck cancer	0.00319	0.00662	CcSEcCtD
Prednisone—Sepsis—Fluorouracil—head and neck cancer	0.00303	0.00628	CcSEcCtD
Prednisone—Euphoric mood—Fluorouracil—head and neck cancer	0.003	0.00622	CcSEcCtD
Prednisone—Pancreatitis—Hydroxyurea—head and neck cancer	0.00298	0.00619	CcSEcCtD
Prednisone—Depression—Vinblastine—head and neck cancer	0.00297	0.00615	CcSEcCtD
Prednisone—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00293	0.00608	CcSEcCtD
Prednisone—Thrombophlebitis—Fluorouracil—head and neck cancer	0.00293	0.00607	CcSEcCtD
Prednisone—Myocardial infarction—Vinblastine—head and neck cancer	0.00292	0.00605	CcSEcCtD
Prednisone—Neuropathy peripheral—Vinblastine—head and neck cancer	0.00292	0.00605	CcSEcCtD
Prednisone—Amenorrhoea—Docetaxel—head and neck cancer	0.00287	0.00595	CcSEcCtD
Prednisone—Neutropenia—Hydroxyurea—head and neck cancer	0.00285	0.0059	CcSEcCtD
Prednisone—HSD11B1—Prostaglandin Synthesis and Regulation—PTGS2—head and neck cancer	0.00281	0.0757	CbGpPWpGaD
Prednisone—Weight increased—Hydroxyurea—head and neck cancer	0.00277	0.00574	CcSEcCtD
Prednisone—Amnesia—Fluorouracil—head and neck cancer	0.0027	0.00559	CcSEcCtD
Prednisone—Haemoglobin—Vinblastine—head and neck cancer	0.00269	0.00557	CcSEcCtD
Prednisone—Haemorrhage—Vinblastine—head and neck cancer	0.00267	0.00554	CcSEcCtD
Prednisone—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00266	0.00552	CcSEcCtD
Prednisone—Cardiac failure—Fluorouracil—head and neck cancer	0.0026	0.00539	CcSEcCtD
Prednisone—Lethargy—Fluorouracil—head and neck cancer	0.00259	0.00536	CcSEcCtD
Prednisone—Osteoarthritis—Fluorouracil—head and neck cancer	0.00254	0.00526	CcSEcCtD
Prednisone—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.00254	0.00526	CcSEcCtD
Prednisone—Haemoglobin—Hydroxyurea—head and neck cancer	0.00245	0.00508	CcSEcCtD
Prednisone—Haemorrhage—Hydroxyurea—head and neck cancer	0.00244	0.00505	CcSEcCtD
Prednisone—Hallucination—Hydroxyurea—head and neck cancer	0.00242	0.00503	CcSEcCtD
Prednisone—Irritability—Fluorouracil—head and neck cancer	0.00242	0.00502	CcSEcCtD
Prednisone—Cardiac arrest—Fluorouracil—head and neck cancer	0.00241	0.005	CcSEcCtD
Prednisone—Skin exfoliation—Docetaxel—head and neck cancer	0.00241	0.00499	CcSEcCtD
Prednisone—Fluid retention—Docetaxel—head and neck cancer	0.00239	0.00496	CcSEcCtD
Prednisone—Neuropathy—Docetaxel—head and neck cancer	0.00237	0.00491	CcSEcCtD
Prednisone—Alopecia—Vinblastine—head and neck cancer	0.00236	0.00489	CcSEcCtD
Prednisone—Dry skin—Fluorouracil—head and neck cancer	0.00232	0.00482	CcSEcCtD
Prednisone—Oesophagitis—Docetaxel—head and neck cancer	0.0023	0.00477	CcSEcCtD
Prednisone—Pulmonary oedema—Docetaxel—head and neck cancer	0.00224	0.00465	CcSEcCtD
Prednisone—Muscular weakness—Fluorouracil—head and neck cancer	0.00224	0.00464	CcSEcCtD
Prednisone—Angiopathy—Hydroxyurea—head and neck cancer	0.00221	0.00458	CcSEcCtD
Prednisone—NR3C1—Transcription factor regulation in adipogenesis—CEBPA—head and neck cancer	0.00221	0.0595	CbGpPWpGaD
Prednisone—Sepsis—Docetaxel—head and neck cancer	0.00219	0.00453	CcSEcCtD
Prednisone—Ill-defined disorder—Vinblastine—head and neck cancer	0.00216	0.00447	CcSEcCtD
Prednisone—Alopecia—Hydroxyurea—head and neck cancer	0.00215	0.00446	CcSEcCtD
Prednisone—Anaemia—Vinblastine—head and neck cancer	0.00215	0.00446	CcSEcCtD
Prednisone—Erythema—Hydroxyurea—head and neck cancer	0.00212	0.0044	CcSEcCtD
Prednisone—Thrombophlebitis—Docetaxel—head and neck cancer	0.00211	0.00438	CcSEcCtD
Prednisone—Malaise—Vinblastine—head and neck cancer	0.0021	0.00435	CcSEcCtD
Prednisone—Vertigo—Vinblastine—head and neck cancer	0.00209	0.00433	CcSEcCtD
Prednisone—Cardiac failure congestive—Docetaxel—head and neck cancer	0.00202	0.00418	CcSEcCtD
Prednisone—Convulsion—Vinblastine—head and neck cancer	0.00202	0.00418	CcSEcCtD
Prednisone—Hypertension—Vinblastine—head and neck cancer	0.00201	0.00416	CcSEcCtD
Prednisone—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00197	0.00408	CcSEcCtD
Prednisone—Clobetasol propionate—CYP1A1—head and neck cancer	0.00197	0.4	CrCbGaD
Prednisone—Anaemia—Hydroxyurea—head and neck cancer	0.00196	0.00406	CcSEcCtD
Prednisone—Discomfort—Vinblastine—head and neck cancer	0.00196	0.00406	CcSEcCtD
Prednisone—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00193	0.00399	CcSEcCtD
Prednisone—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00192	0.00397	CcSEcCtD
Prednisone—Myocardial infarction—Fluorouracil—head and neck cancer	0.00192	0.00397	CcSEcCtD
Prednisone—Malaise—Hydroxyurea—head and neck cancer	0.00191	0.00397	CcSEcCtD
Prednisone—Cardiac failure—Docetaxel—head and neck cancer	0.00187	0.00389	CcSEcCtD
Prednisone—Lethargy—Docetaxel—head and neck cancer	0.00187	0.00387	CcSEcCtD
Prednisone—Convulsion—Hydroxyurea—head and neck cancer	0.00184	0.00381	CcSEcCtD
Prednisone—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.00183	0.00379	CcSEcCtD
Prednisone—Anorexia—Vinblastine—head and neck cancer	0.00181	0.00375	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00179	0.00372	CcSEcCtD
Prednisone—Discomfort—Hydroxyurea—head and neck cancer	0.00178	0.0037	CcSEcCtD
Prednisone—Haemoglobin—Fluorouracil—head and neck cancer	0.00176	0.00365	CcSEcCtD
Prednisone—Haemorrhage—Fluorouracil—head and neck cancer	0.00175	0.00364	CcSEcCtD
Prednisone—Oedema—Hydroxyurea—head and neck cancer	0.00173	0.00359	CcSEcCtD
Prednisone—Infection—Hydroxyurea—head and neck cancer	0.00172	0.00357	CcSEcCtD
Prednisone—Paraesthesia—Vinblastine—head and neck cancer	0.0017	0.00353	CcSEcCtD
Prednisone—Nervous system disorder—Hydroxyurea—head and neck cancer	0.0017	0.00352	CcSEcCtD
Prednisone—Skin disorder—Hydroxyurea—head and neck cancer	0.00168	0.00349	CcSEcCtD
Prednisone—Dry skin—Docetaxel—head and neck cancer	0.00168	0.00348	CcSEcCtD
Prednisone—Anorexia—Hydroxyurea—head and neck cancer	0.00165	0.00342	CcSEcCtD
Prednisone—Decreased appetite—Vinblastine—head and neck cancer	0.00165	0.00342	CcSEcCtD
Prednisone—Constipation—Vinblastine—head and neck cancer	0.00162	0.00337	CcSEcCtD
Prednisone—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.00161	0.00335	CcSEcCtD
Prednisone—Arrhythmia—Fluorouracil—head and neck cancer	0.00157	0.00325	CcSEcCtD
Prednisone—Feeling abnormal—Vinblastine—head and neck cancer	0.00156	0.00324	CcSEcCtD
Prednisone—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00155	0.00322	CcSEcCtD
Prednisone—Alopecia—Fluorouracil—head and neck cancer	0.00155	0.00321	CcSEcCtD
Prednisone—Erythema—Fluorouracil—head and neck cancer	0.00153	0.00316	CcSEcCtD
Prednisone—Dyspepsia—Hydroxyurea—head and neck cancer	0.00152	0.00316	CcSEcCtD
Prednisone—Decreased appetite—Hydroxyurea—head and neck cancer	0.0015	0.00312	CcSEcCtD
Prednisone—Abdominal pain—Vinblastine—head and neck cancer	0.0015	0.00311	CcSEcCtD
Prednisone—Fatigue—Hydroxyurea—head and neck cancer	0.00149	0.00309	CcSEcCtD
Prednisone—Constipation—Hydroxyurea—head and neck cancer	0.00148	0.00307	CcSEcCtD
Prednisone—Neutropenia—Docetaxel—head and neck cancer	0.00148	0.00307	CcSEcCtD
Prednisone—Weight increased—Docetaxel—head and neck cancer	0.00144	0.00298	CcSEcCtD
Prednisone—Vision blurred—Fluorouracil—head and neck cancer	0.00144	0.00298	CcSEcCtD
Prednisone—Weight decreased—Docetaxel—head and neck cancer	0.00143	0.00297	CcSEcCtD
Prednisone—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00143	0.00296	CcSEcCtD
Prednisone—Anaemia—Fluorouracil—head and neck cancer	0.00141	0.00293	CcSEcCtD
Prednisone—Hypersensitivity—Vinblastine—head and neck cancer	0.0014	0.0029	CcSEcCtD
Prednisone—Acute coronary syndrome—Docetaxel—head and neck cancer	0.00139	0.00288	CcSEcCtD
Prednisone—Myocardial infarction—Docetaxel—head and neck cancer	0.00138	0.00287	CcSEcCtD
Prednisone—Neuropathy peripheral—Docetaxel—head and neck cancer	0.00138	0.00287	CcSEcCtD
Prednisone—Body temperature increased—Hydroxyurea—head and neck cancer	0.00137	0.00284	CcSEcCtD
Prednisone—Asthenia—Vinblastine—head and neck cancer	0.00136	0.00282	CcSEcCtD
Prednisone—Convulsion—Fluorouracil—head and neck cancer	0.00132	0.00274	CcSEcCtD
Prednisone—Myalgia—Fluorouracil—head and neck cancer	0.0013	0.00269	CcSEcCtD
Prednisone—Diarrhoea—Vinblastine—head and neck cancer	0.0013	0.00269	CcSEcCtD
Prednisone—Discomfort—Fluorouracil—head and neck cancer	0.00128	0.00266	CcSEcCtD
Prednisone—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00128	0.00264	CcSEcCtD
Prednisone—Haemoglobin—Docetaxel—head and neck cancer	0.00127	0.00264	CcSEcCtD
Prednisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—CEBPA—head and neck cancer	0.00127	0.0342	CbGpPWpGaD
Prednisone—Haemorrhage—Docetaxel—head and neck cancer	0.00127	0.00262	CcSEcCtD
Prednisone—Dizziness—Vinblastine—head and neck cancer	0.00126	0.0026	CcSEcCtD
Prednisone—Oedema—Fluorouracil—head and neck cancer	0.00125	0.00258	CcSEcCtD
Prednisone—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00125	0.00258	CcSEcCtD
Prednisone—Connective tissue disorder—Docetaxel—head and neck cancer	0.00124	0.00258	CcSEcCtD
Prednisone—Asthenia—Hydroxyurea—head and neck cancer	0.00124	0.00257	CcSEcCtD
Prednisone—Infection—Fluorouracil—head and neck cancer	0.00124	0.00257	CcSEcCtD
Prednisone—Nervous system disorder—Fluorouracil—head and neck cancer	0.00122	0.00253	CcSEcCtD
Prednisone—Tachycardia—Fluorouracil—head and neck cancer	0.00122	0.00252	CcSEcCtD
Prednisone—Vomiting—Vinblastine—head and neck cancer	0.00121	0.0025	CcSEcCtD
Prednisone—Headache—Vinblastine—head and neck cancer	0.00119	0.00247	CcSEcCtD
Prednisone—Anorexia—Fluorouracil—head and neck cancer	0.00119	0.00246	CcSEcCtD
Prednisone—Diarrhoea—Hydroxyurea—head and neck cancer	0.00118	0.00246	CcSEcCtD
Prednisone—Eye disorder—Docetaxel—head and neck cancer	0.00118	0.00245	CcSEcCtD
Prednisone—Flushing—Docetaxel—head and neck cancer	0.00117	0.00244	CcSEcCtD
Prednisone—Angiopathy—Docetaxel—head and neck cancer	0.00115	0.00238	CcSEcCtD
Prednisone—Dizziness—Hydroxyurea—head and neck cancer	0.00114	0.00237	CcSEcCtD
Prednisone—Immune system disorder—Docetaxel—head and neck cancer	0.00114	0.00237	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00114	0.00235	CcSEcCtD
Prednisone—Arrhythmia—Docetaxel—head and neck cancer	0.00113	0.00234	CcSEcCtD
Prednisone—Nausea—Vinblastine—head and neck cancer	0.00113	0.00234	CcSEcCtD
Prednisone—Insomnia—Fluorouracil—head and neck cancer	0.00113	0.00234	CcSEcCtD
Prednisone—Paraesthesia—Fluorouracil—head and neck cancer	0.00112	0.00232	CcSEcCtD
Prednisone—Alopecia—Docetaxel—head and neck cancer	0.00112	0.00232	CcSEcCtD
Prednisone—Mental disorder—Docetaxel—head and neck cancer	0.00111	0.0023	CcSEcCtD
Prednisone—NR3C1—Nuclear Receptors—RARB—head and neck cancer	0.00111	0.0299	CbGpPWpGaD
Prednisone—Erythema—Docetaxel—head and neck cancer	0.0011	0.00228	CcSEcCtD
Prednisone—Malnutrition—Docetaxel—head and neck cancer	0.0011	0.00228	CcSEcCtD
Prednisone—Vomiting—Hydroxyurea—head and neck cancer	0.0011	0.00228	CcSEcCtD
Prednisone—Dyspepsia—Fluorouracil—head and neck cancer	0.0011	0.00227	CcSEcCtD
Prednisone—NR3C1—Regulation of Androgen receptor activity—CEBPA—head and neck cancer	0.00109	0.0294	CbGpPWpGaD
Prednisone—Rash—Hydroxyurea—head and neck cancer	0.00109	0.00226	CcSEcCtD
Prednisone—Dermatitis—Hydroxyurea—head and neck cancer	0.00109	0.00226	CcSEcCtD
Prednisone—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.00109	0.0293	CbGpPWpGaD
Prednisone—Headache—Hydroxyurea—head and neck cancer	0.00108	0.00225	CcSEcCtD
Prednisone—Decreased appetite—Fluorouracil—head and neck cancer	0.00108	0.00225	CcSEcCtD
Prednisone—Nausea—Hydroxyurea—head and neck cancer	0.00103	0.00213	CcSEcCtD
Prednisone—HSD11B1—Metabolism—UROD—head and neck cancer	0.00103	0.0277	CbGpPWpGaD
Prednisone—Feeling abnormal—Fluorouracil—head and neck cancer	0.00103	0.00213	CcSEcCtD
Prednisone—Anaemia—Docetaxel—head and neck cancer	0.00102	0.00211	CcSEcCtD
Prednisone—Urticaria—Fluorouracil—head and neck cancer	0.00099	0.00205	CcSEcCtD
Prednisone—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.000989	0.0266	CbGpPWpGaD
Prednisone—Syncope—Docetaxel—head and neck cancer	0.000988	0.00205	CcSEcCtD
Prednisone—Body temperature increased—Fluorouracil—head and neck cancer	0.000985	0.00204	CcSEcCtD
Prednisone—Loss of consciousness—Docetaxel—head and neck cancer	0.000968	0.00201	CcSEcCtD
Prednisone—Triamcinolone—PTGS2—head and neck cancer	0.000965	0.196	CrCbGaD
Prednisone—Convulsion—Docetaxel—head and neck cancer	0.000955	0.00198	CcSEcCtD
Prednisone—Hypertension—Docetaxel—head and neck cancer	0.000951	0.00197	CcSEcCtD
Prednisone—Arthralgia—Docetaxel—head and neck cancer	0.000938	0.00194	CcSEcCtD
Prednisone—Myalgia—Docetaxel—head and neck cancer	0.000938	0.00194	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000932	0.00193	CcSEcCtD
Prednisone—Hypersensitivity—Fluorouracil—head and neck cancer	0.000918	0.0019	CcSEcCtD
Prednisone—Oedema—Docetaxel—head and neck cancer	0.000899	0.00186	CcSEcCtD
Prednisone—Anaphylactic shock—Docetaxel—head and neck cancer	0.000899	0.00186	CcSEcCtD
Prednisone—Infection—Docetaxel—head and neck cancer	0.000893	0.00185	CcSEcCtD
Prednisone—Shock—Docetaxel—head and neck cancer	0.000885	0.00183	CcSEcCtD
Prednisone—Nervous system disorder—Docetaxel—head and neck cancer	0.000882	0.00183	CcSEcCtD
Prednisone—Pruritus—Fluorouracil—head and neck cancer	0.000882	0.00183	CcSEcCtD
Prednisone—Tachycardia—Docetaxel—head and neck cancer	0.000878	0.00182	CcSEcCtD
Prednisone—NR3C1—Nuclear Receptor transcription pathway—RARB—head and neck cancer	0.000876	0.0236	CbGpPWpGaD
Prednisone—Skin disorder—Docetaxel—head and neck cancer	0.000874	0.00181	CcSEcCtD
Prednisone—Anorexia—Docetaxel—head and neck cancer	0.000857	0.00178	CcSEcCtD
Prednisone—Diarrhoea—Fluorouracil—head and neck cancer	0.000853	0.00177	CcSEcCtD
Prednisone—Dizziness—Fluorouracil—head and neck cancer	0.000824	0.00171	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000819	0.0017	CcSEcCtD
Prednisone—Insomnia—Docetaxel—head and neck cancer	0.000813	0.00169	CcSEcCtD
Prednisone—Paraesthesia—Docetaxel—head and neck cancer	0.000808	0.00167	CcSEcCtD
Prednisone—HSD11B1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000798	0.0215	CbGpPWpGaD
Prednisone—Vomiting—Fluorouracil—head and neck cancer	0.000792	0.00164	CcSEcCtD
Prednisone—Dyspepsia—Docetaxel—head and neck cancer	0.000792	0.00164	CcSEcCtD
Prednisone—Betamethasone—PTGS2—head and neck cancer	0.000791	0.161	CrCbGaD
Prednisone—Rash—Fluorouracil—head and neck cancer	0.000786	0.00163	CcSEcCtD
Prednisone—Dermatitis—Fluorouracil—head and neck cancer	0.000785	0.00163	CcSEcCtD
Prednisone—Decreased appetite—Docetaxel—head and neck cancer	0.000782	0.00162	CcSEcCtD
Prednisone—Headache—Fluorouracil—head and neck cancer	0.000781	0.00162	CcSEcCtD
Prednisone—ALB—FOXA2 and FOXA3 transcription factor networks—CEBPA—head and neck cancer	0.000777	0.0209	CbGpPWpGaD
Prednisone—Fatigue—Docetaxel—head and neck cancer	0.000775	0.00161	CcSEcCtD
Prednisone—Constipation—Docetaxel—head and neck cancer	0.000769	0.00159	CcSEcCtD
Prednisone—CYP3A4—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.000767	0.0207	CbGpPWpGaD
Prednisone—Feeling abnormal—Docetaxel—head and neck cancer	0.000741	0.00154	CcSEcCtD
Prednisone—Nausea—Fluorouracil—head and neck cancer	0.00074	0.00153	CcSEcCtD
Prednisone—Dexamethasone—CYP1A1—head and neck cancer	0.000736	0.15	CrCbGaD
Prednisone—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000735	0.00152	CcSEcCtD
Prednisone—Abdominal pain—Docetaxel—head and neck cancer	0.000711	0.00147	CcSEcCtD
Prednisone—Body temperature increased—Docetaxel—head and neck cancer	0.000711	0.00147	CcSEcCtD
Prednisone—Hypersensitivity—Docetaxel—head and neck cancer	0.000663	0.00137	CcSEcCtD
Prednisone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000651	0.0175	CbGpPWpGaD
Prednisone—Asthenia—Docetaxel—head and neck cancer	0.000645	0.00134	CcSEcCtD
Prednisone—Pruritus—Docetaxel—head and neck cancer	0.000636	0.00132	CcSEcCtD
Prednisone—Diarrhoea—Docetaxel—head and neck cancer	0.000615	0.00128	CcSEcCtD
Prednisone—Dizziness—Docetaxel—head and neck cancer	0.000595	0.00123	CcSEcCtD
Prednisone—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—head and neck cancer	0.000595	0.016	CbGpPWpGaD
Prednisone—Vomiting—Docetaxel—head and neck cancer	0.000572	0.00119	CcSEcCtD
Prednisone—Rash—Docetaxel—head and neck cancer	0.000567	0.00118	CcSEcCtD
Prednisone—Dermatitis—Docetaxel—head and neck cancer	0.000567	0.00117	CcSEcCtD
Prednisone—Headache—Docetaxel—head and neck cancer	0.000563	0.00117	CcSEcCtD
Prednisone—Nausea—Docetaxel—head and neck cancer	0.000534	0.00111	CcSEcCtD
Prednisone—NR3C1—Adipogenesis—CEBPA—head and neck cancer	0.000533	0.0144	CbGpPWpGaD
Prednisone—CYP2C19—Xenobiotics—CYP1A1—head and neck cancer	0.000522	0.0141	CbGpPWpGaD
Prednisone—CYP2C19—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000502	0.0135	CbGpPWpGaD
Prednisone—Dexamethasone—PTGS2—head and neck cancer	0.00046	0.0935	CrCbGaD
Prednisone—HSD11B1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000453	0.0122	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000449	0.0121	CbGpPWpGaD
Prednisone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—head and neck cancer	0.000438	0.0118	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—NAT2—head and neck cancer	0.000427	0.0115	CbGpPWpGaD
Prednisone—NR3C1—Adipogenesis—STAT6—head and neck cancer	0.000426	0.0115	CbGpPWpGaD
Prednisone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK1—head and neck cancer	0.000417	0.0112	CbGpPWpGaD
Prednisone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000401	0.0108	CbGpPWpGaD
Prednisone—CYP2C19—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000388	0.0105	CbGpPWpGaD
Prednisone—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000375	0.0101	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—DPYD—head and neck cancer	0.000374	0.0101	CbGpPWpGaD
Prednisone—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	0.00036	0.00971	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—YAP1—head and neck cancer	0.000355	0.00957	CbGpPWpGaD
Prednisone—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.000342	0.0092	CbGpPWpGaD
Prednisone—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.000314	0.00846	CbGpPWpGaD
Prednisone—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000302	0.00814	CbGpPWpGaD
Prednisone—ALB—Vitamin B12 Metabolism—SOD2—head and neck cancer	0.000291	0.00785	CbGpPWpGaD
Prednisone—NR3C1—Endoderm Differentiation—NOTCH1—head and neck cancer	0.000285	0.00769	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000267	0.00719	CbGpPWpGaD
Prednisone—CYP2C19—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000253	0.00683	CbGpPWpGaD
Prednisone—CYP2C19—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000251	0.00676	CbGpPWpGaD
Prednisone—ALB—Folate Metabolism—SOD2—head and neck cancer	0.000237	0.00638	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000233	0.00627	CbGpPWpGaD
Prednisone—ALB—Folate Metabolism—GPX1—head and neck cancer	0.000226	0.00609	CbGpPWpGaD
Prednisone—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000217	0.00584	CbGpPWpGaD
Prednisone—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000214	0.00576	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—TYMS—head and neck cancer	0.000213	0.00575	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—GSTM1—head and neck cancer	0.000211	0.00568	CbGpPWpGaD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.00021	0.00566	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—GPX1—head and neck cancer	0.000202	0.00544	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—CYP1A1—head and neck cancer	0.0002	0.00539	CbGpPWpGaD
Prednisone—CYP2C19—Biological oxidations—NAT2—head and neck cancer	0.000199	0.00537	CbGpPWpGaD
Prednisone—CYP2C19—Metapathway biotransformation—NAT2—head and neck cancer	0.000197	0.0053	CbGpPWpGaD
Prednisone—NR3C1—AP-1 transcription factor network—IL2—head and neck cancer	0.000192	0.00517	CbGpPWpGaD
Prednisone—ALB—Selenium Micronutrient Network—SOD2—head and neck cancer	0.000188	0.00507	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—UROD—head and neck cancer	0.000187	0.00504	CbGpPWpGaD
Prednisone—NR3C1—AP-1 transcription factor network—CCND1—head and neck cancer	0.000187	0.00504	CbGpPWpGaD
Prednisone—NR3C1—AP-1 transcription factor network—PTEN—head and neck cancer	0.000181	0.00487	CbGpPWpGaD
Prednisone—ALB—Selenium Micronutrient Network—GPX1—head and neck cancer	0.00018	0.00484	CbGpPWpGaD
Prednisone—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000176	0.00474	CbGpPWpGaD
Prednisone—NR3C1—Glucocorticoid receptor regulatory network—IL2—head and neck cancer	0.000169	0.00456	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	0.000164	0.00442	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.000164	0.00441	CbGpPWpGaD
Prednisone—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000161	0.00434	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—RARB—head and neck cancer	0.000151	0.00408	CbGpPWpGaD
Prednisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—head and neck cancer	0.000151	0.00407	CbGpPWpGaD
Prednisone—CYP2C19—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000149	0.00402	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.000149	0.00401	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000145	0.00391	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—YAP1—head and neck cancer	0.000138	0.00371	CbGpPWpGaD
Prednisone—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—head and neck cancer	0.000136	0.00366	CbGpPWpGaD
Prednisone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.00013	0.00351	CbGpPWpGaD
Prednisone—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—head and neck cancer	0.000129	0.00349	CbGpPWpGaD
Prednisone—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000129	0.00347	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—CASP8—head and neck cancer	0.000124	0.00334	CbGpPWpGaD
Prednisone—ALB—Folate Metabolism—IL2—head and neck cancer	0.000123	0.00332	CbGpPWpGaD
Prednisone—NR3C1—AP-1 transcription factor network—TP53—head and neck cancer	0.000123	0.00332	CbGpPWpGaD
Prednisone—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.00012	0.00323	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—PTGS2—head and neck cancer	0.000119	0.0032	CbGpPWpGaD
Prednisone—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.000118	0.00319	CbGpPWpGaD
Prednisone—NR3C1—Glucocorticoid receptor regulatory network—TP53—head and neck cancer	0.000109	0.00293	CbGpPWpGaD
Prednisone—ALB—Selenium Micronutrient Network—PTGS2—head and neck cancer	0.000106	0.00285	CbGpPWpGaD
Prednisone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000106	0.00285	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—PTEN—head and neck cancer	0.000104	0.00279	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000103	0.00276	CbGpPWpGaD
Prednisone—CYP2C19—Biological oxidations—GSTM1—head and neck cancer	9.85e-05	0.00265	CbGpPWpGaD
Prednisone—NR3C1—Adipogenesis—STAT3—head and neck cancer	9.84e-05	0.00265	CbGpPWpGaD
Prednisone—CYP2C19—Metapathway biotransformation—GSTM1—head and neck cancer	9.71e-05	0.00262	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—IL2—head and neck cancer	9.36e-05	0.00252	CbGpPWpGaD
Prednisone—CYP2C19—Biological oxidations—CYP1A1—head and neck cancer	9.33e-05	0.00252	CbGpPWpGaD
Prednisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—head and neck cancer	9.26e-05	0.0025	CbGpPWpGaD
Prednisone—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—head and neck cancer	9.25e-05	0.00249	CbGpPWpGaD
Prednisone—CYP2C19—Metapathway biotransformation—CYP1A1—head and neck cancer	9.21e-05	0.00248	CbGpPWpGaD
Prednisone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	9.18e-05	0.00247	CbGpPWpGaD
Prednisone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—head and neck cancer	9.17e-05	0.00247	CbGpPWpGaD
Prednisone—ALB—Metabolism—UROD—head and neck cancer	9.15e-05	0.00246	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	8.99e-05	0.00242	CbGpPWpGaD
Prednisone—ALB—Platelet degranulation—VEGFA—head and neck cancer	8.99e-05	0.00242	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	8.94e-05	0.00241	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	8.59e-05	0.00231	CbGpPWpGaD
Prednisone—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—head and neck cancer	8.56e-05	0.00231	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	8.26e-05	0.00222	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—UROD—head and neck cancer	8.21e-05	0.00221	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	8.17e-05	0.0022	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—UROD—head and neck cancer	8.01e-05	0.00216	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—VEGFA—head and neck cancer	7.95e-05	0.00214	CbGpPWpGaD
Prednisone—ALB—Folate Metabolism—TP53—head and neck cancer	7.92e-05	0.00213	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—NAT2—head and neck cancer	7.77e-05	0.00209	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—PIK3CA—head and neck cancer	7.31e-05	0.00197	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—RARB—head and neck cancer	7.29e-05	0.00196	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	7.1e-05	0.00191	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—DPYD—head and neck cancer	6.82e-05	0.00184	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—YAP1—head and neck cancer	6.63e-05	0.00179	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—YAP1—head and neck cancer	6.47e-05	0.00174	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	6.37e-05	0.00172	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—NOTCH1—head and neck cancer	6.2e-05	0.00167	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	6.11e-05	0.00165	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—AKT1—head and neck cancer	5.97e-05	0.00161	CbGpPWpGaD
Prednisone—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	5.92e-05	0.0016	CbGpPWpGaD
Prednisone—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	5.86e-05	0.00158	CbGpPWpGaD
Prednisone—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	5.84e-05	0.00157	CbGpPWpGaD
Prednisone—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	5.61e-05	0.00151	CbGpPWpGaD
Prednisone—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	5.54e-05	0.00149	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	5.24e-05	0.00141	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	4.98e-05	0.00134	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—UROD—head and neck cancer	4.94e-05	0.00133	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	4.86e-05	0.00131	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—IL2—head and neck cancer	4.69e-05	0.00126	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	4.5e-05	0.00121	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	4.35e-05	0.00117	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	4.24e-05	0.00114	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	4.03e-05	0.00109	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	3.99e-05	0.00108	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—VEGFA—head and neck cancer	3.99e-05	0.00107	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	3.92e-05	0.00106	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—TYMS—head and neck cancer	3.88e-05	0.00105	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—GSTM1—head and neck cancer	3.84e-05	0.00103	CbGpPWpGaD
Prednisone—ALB—Metabolism—NAT2—head and neck cancer	3.8e-05	0.00102	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—MAPK3—head and neck cancer	3.77e-05	0.00102	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	3.71e-05	0.001	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—GPX1—head and neck cancer	3.68e-05	0.000991	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—CYP1A1—head and neck cancer	3.64e-05	0.000981	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	3.62e-05	0.000976	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—MAPK1—head and neck cancer	3.59e-05	0.000967	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	3.58e-05	0.000966	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	3.53e-05	0.000952	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	3.53e-05	0.000952	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—NAT2—head and neck cancer	3.41e-05	0.000919	CbGpPWpGaD
Prednisone—ALB—Metabolism—DPYD—head and neck cancer	3.33e-05	0.000897	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—NAT2—head and neck cancer	3.33e-05	0.000897	CbGpPWpGaD
Prednisone—ALB—Metabolism—YAP1—head and neck cancer	3.16e-05	0.000852	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—PIK3CA—head and neck cancer	3.11e-05	0.000839	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	3.07e-05	0.000826	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.99e-05	0.000806	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—DPYD—head and neck cancer	2.99e-05	0.000806	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—NOTCH1—head and neck cancer	2.99e-05	0.000805	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	2.97e-05	0.000799	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—DPYD—head and neck cancer	2.92e-05	0.000786	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—YAP1—head and neck cancer	2.84e-05	0.000765	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—YAP1—head and neck cancer	2.77e-05	0.000746	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—AKT1—head and neck cancer	2.54e-05	0.000685	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	2.5e-05	0.000675	CbGpPWpGaD
Prednisone—ALB—Hemostasis—IL2—head and neck cancer	2.42e-05	0.000651	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.37e-05	0.00064	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PTGS2—head and neck cancer	2.16e-05	0.000583	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.13e-05	0.000574	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.07e-05	0.000558	CbGpPWpGaD
Prednisone—ALB—Hemostasis—VEGFA—head and neck cancer	2.05e-05	0.000554	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—NAT2—head and neck cancer	2.05e-05	0.000553	CbGpPWpGaD
Prednisone—ALB—Hemostasis—MAPK3—head and neck cancer	1.94e-05	0.000524	CbGpPWpGaD
Prednisone—ALB—Metabolism—TYMS—head and neck cancer	1.9e-05	0.000511	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PTEN—head and neck cancer	1.89e-05	0.000509	CbGpPWpGaD
Prednisone—ALB—Metabolism—GSTM1—head and neck cancer	1.88e-05	0.000506	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.86e-05	0.000501	CbGpPWpGaD
Prednisone—ALB—Hemostasis—MAPK1—head and neck cancer	1.85e-05	0.000498	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—DPYD—head and neck cancer	1.8e-05	0.000484	CbGpPWpGaD
Prednisone—ALB—Metabolism—GPX1—head and neck cancer	1.8e-05	0.000484	CbGpPWpGaD
Prednisone—ALB—Metabolism—CYP1A1—head and neck cancer	1.78e-05	0.000479	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—YAP1—head and neck cancer	1.71e-05	0.00046	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—TYMS—head and neck cancer	1.7e-05	0.000459	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GSTM1—head and neck cancer	1.68e-05	0.000454	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—TYMS—head and neck cancer	1.66e-05	0.000448	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—MAPK3—head and neck cancer	1.65e-05	0.000445	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GSTM1—head and neck cancer	1.64e-05	0.000443	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GPX1—head and neck cancer	1.61e-05	0.000435	CbGpPWpGaD
Prednisone—ALB—Hemostasis—PIK3CA—head and neck cancer	1.6e-05	0.000432	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CYP1A1—head and neck cancer	1.6e-05	0.00043	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GPX1—head and neck cancer	1.57e-05	0.000424	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CYP1A1—head and neck cancer	1.56e-05	0.00042	CbGpPWpGaD
Prednisone—ALB—Hemostasis—TP53—head and neck cancer	1.55e-05	0.000418	CbGpPWpGaD
Prednisone—ALB—Hemostasis—HRAS—head and neck cancer	1.48e-05	0.0004	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.46e-05	0.000394	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PIK3CA—head and neck cancer	1.33e-05	0.000359	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.31e-05	0.000353	CbGpPWpGaD
Prednisone—ALB—Hemostasis—AKT1—head and neck cancer	1.31e-05	0.000353	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—AKT1—head and neck cancer	1.11e-05	0.0003	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—AKT1—head and neck cancer	1.09e-05	0.000293	CbGpPWpGaD
Prednisone—ALB—Metabolism—PTGS2—head and neck cancer	1.06e-05	0.000285	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—TYMS—head and neck cancer	1.02e-05	0.000276	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GSTM1—head and neck cancer	1.01e-05	0.000273	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GPX1—head and neck cancer	9.7e-06	0.000261	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CYP1A1—head and neck cancer	9.6e-06	0.000259	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PTGS2—head and neck cancer	9.49e-06	0.000256	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PTGS2—head and neck cancer	9.27e-06	0.00025	CbGpPWpGaD
Prednisone—ALB—Metabolism—PTEN—head and neck cancer	9.22e-06	0.000249	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PTEN—head and neck cancer	8.28e-06	0.000223	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PTEN—head and neck cancer	8.08e-06	0.000218	CbGpPWpGaD
Prednisone—ALB—Metabolism—PIK3CA—head and neck cancer	6.51e-06	0.000175	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PIK3CA—head and neck cancer	5.84e-06	0.000157	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PTGS2—head and neck cancer	5.71e-06	0.000154	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PIK3CA—head and neck cancer	5.7e-06	0.000154	CbGpPWpGaD
Prednisone—ALB—Metabolism—AKT1—head and neck cancer	5.31e-06	0.000143	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PTEN—head and neck cancer	4.98e-06	0.000134	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—AKT1—head and neck cancer	4.77e-06	0.000129	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—AKT1—head and neck cancer	4.66e-06	0.000125	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PIK3CA—head and neck cancer	3.51e-06	9.46e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—AKT1—head and neck cancer	2.87e-06	7.73e-05	CbGpPWpGaD
